REQUEST A DEMO
Total
USD $0.00
Search more companies

Rudraksh Pharma And Surgico Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rudraksh Pharma And Surgico Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Rudraksh Pharma And Surgico Private Limited is an enterprise in India, with the main office in Ahmedabad. The company operates in the Pharmaceutical and Medicine Manufacturing sector. Rudraksh Pharma And Surgico Private Limited was incorporated on April 06, 1995. The total number of employees is currently 7 (2026). From the latest financial highlights, Rudraksh Pharma And Surgico Private Limited reported a net sales revenue increase of 9.19% in 2025. A growth of 22.32% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 0.42%.

Legal Address
176/6, G.I.D.C. Phase-I, Naroda
Ahmedabad; Gujarat; Postal Code: 382330

Contact Details: Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Registered Capital:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Financial Auditors:
Purchase the Rudraksh Pharma And Surgico Private Limited report to view the information.
Incorporation Date:
April 06, 1995
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Rudraksh Pharma And Surgico Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.19%
Total Operating Revenue
9.24%
Operating Profit
29.84%
EBITDA
28.7%
Net Profit/Loss for the Period
24.07%
Total Assets
22.32%
Total Equity
13.39%
Operating Profit Margin
0.86%
Net Profit Margin
0.42%
Return on Equity (ROE)
1.02%
Debt / Equity
11.65%
Quick Ratio
-0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?